# Cellectar Biosciences, Inc.: Form 8-K, filed Jun 7, 2022

- Company: [Cellectar Biosciences, Inc.](/companies/clrb.md) (CIK 1279704)
- Form: 8-K
- Filed: 2022-06-07
- Accepted by EDGAR: Jun 6, 2022, 19:18 ET
- Period: 2022-06-06
- Accession: 0001104659-22-068653
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1279704/000110465922068653/tm2217846d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1279704/000110465922068653/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1279704/000110465922068653/tm2217846d1_8k.htm

Filed Jun 7, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-068653. Last ingested by Listed: Nov 10, 2026, 16:55 ET. No prices; not investment advice.
